These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10227752)

  • 1. Changes in plasma levels of cyclic nucleotides during low-density lipoprotein apheresis.
    Kojima S; Yoshitomi Y; Sugi T; Matsumoto Y; Yano M; Kuramochi M
    Ther Apher; 1998 Nov; 2(4):263-7. PubMed ID: 10227752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in bradykinin and prostaglandins plasma levels during dextran-sulfate low-density-lipoprotein apheresis.
    Kojima S; Ogi M; Yoshitomi Y; Kuramochi M; Ikeda J; Naganawa M; Hatakeyama H
    Int J Artif Organs; 1997 Mar; 20(3):178-83. PubMed ID: 9151155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis.
    Kojima S; Shiba M; Kuramochi M; Yamamoto A
    Artif Organs; 1995 Feb; 19(2):135-9. PubMed ID: 7763192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in plasma levels of nitric oxide derivative during low-density lipoprotein apheresis.
    Kojima S; Ogi M; Sugi T; Matsumoto Y; Yoshitomi Y; Kuramochi M
    Ther Apher; 1997 Nov; 1(4):356-61. PubMed ID: 10225731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
    Kizaki Y; Ueki Y; Yoshida K; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
    Blood Coagul Fibrinolysis; 1999 Sep; 10(6):341-9. PubMed ID: 10493215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of nafamostat mesilate on bradykinin generation during low-density lipoprotein apheresis using a dextran sulfate cellulose column.
    Kojima S; Harada-Shiba M; Nomura S; Kimura G; Tsushima M; Kuramochi M; Yamamoto A; Omae T
    ASAIO Trans; 1991; 37(4):644-8. PubMed ID: 1768503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composition and immunoreactivity of serum low density lipoproteins (LDL) before and after LDL-apheresis on dextran sulfate-cellulose columns.
    Gandjini H; Gambert P; Athias A; Mousson C; Rifle G; Lallemant C
    Transfus Sci; 1994 Sep; 15(3):289-97. PubMed ID: 10155547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of low-density lipoprotein from plasma by adsorption increases bradykinin and plasma nitric oxide levels in patients with peripheral atherosclerosis.
    Murashima J; Ueki Y; Matsunaga Y; Yano M; Matsumoto K; Miyake S; Tominaga Y; Eguchi K; Yano K
    Blood Coagul Fibrinolysis; 1998 Nov; 9(8):725-32. PubMed ID: 9890715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in coagulation factors by passage through a dextran sulfate cellulose column during low-density lipoprotein apheresis.
    Kojima S; Harada-Shiba M; Toyota Y; Kimura G; Tsushima M; Kuramochi M; Sakata T; Uchida K; Yamamoto A; Omae T
    Int J Artif Organs; 1992 Mar; 15(3):185-90. PubMed ID: 1521904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of losartan on low-density lipoprotein apheresis.
    Kojima S; Yoshitomi Y; Saotome M; Tanaka K; Shida M; Kuramochi M
    Ther Apher; 1999 Nov; 3(4):303-6. PubMed ID: 10608722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma dependent reduction in red blood cell aggregation after dextran sulfate low-density lipoprotein apheresis--implications for rheological studies.
    Schechner V; Ben-Ami R; Hershcovici T; Yedgar S; Beigel Y; Shapira I; Berliner S; Barsthein G
    Ther Apher Dial; 2005 Oct; 9(5):379-84. PubMed ID: 16202011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contact activation in low-density lipoprotein apheresis systems.
    Krieter DH; Steinke J; Kerkhoff M; Fink E; Lemke HD; Zingler C; Müller GA; Schuff-Werner P
    Artif Organs; 2005 Jan; 29(1):47-52. PubMed ID: 15644083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast transmission of alterations in plasma phosphatidylcholine/sphingomyelin ratio and lyso phosphatidylcholine levels into changes of red blood cell membrane phospholipid composition after low density lipoprotein apheresis.
    Kulschar R; Engelmann B; Bräutigam C; Duhm J; Thiery J; Richter WO
    Eur J Clin Invest; 1995 Apr; 25(4):258-65. PubMed ID: 7601201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatment.
    Leitinger N; Pirich C; Blazek I; Endler G; Sinzinger H
    Atherosclerosis; 1996 Oct; 126(2):305-12. PubMed ID: 8902156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis.
    Donner MG; Parhofer KG; Richter WO; Schwandt P
    Metabolism; 1999 Jul; 48(7):881-6. PubMed ID: 10421230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of losartan on blood pressure and humoral factors in a patient who suffered from anaphylactoid reactions when treated with ACE inhibitors during LDL apheresis.
    Kojima S; Shida M; Takano H; Inami S; Yodogawa K; Yokoyama H; Kuramochi M
    Hypertens Res; 2001 Sep; 24(5):595-8. PubMed ID: 11675956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of hyperlipidemia with a modified low density lipoprotein apheresis system with dextran sulfate.
    Zhao YH; Zou YG; Sun QJ; Xi D; Xing CY
    Ther Apher Dial; 2007 Aug; 11(4):249-54. PubMed ID: 17661829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid reductions by low-density lipoprotein apheresis: a comparison of three systems.
    Jovin IS; Taborski U; Stehr A; Müller-Berghaus G
    Metabolism; 2000 Nov; 49(11):1431-3. PubMed ID: 11092506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two low-density lipoprotein apheresis systems in patients with homozygous familial hypercholesterolemia.
    Drouin-Chartier JP; Tremblay AJ; Bergeron J; Pelletier M; Laflamme N; Lamarche B; Couture P
    J Clin Apher; 2016 Aug; 31(4):359-67. PubMed ID: 26011648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of selective low-density lipoprotein (LDL) apheresis system: immobilized polyanion as LDL-specific adsorption for LDL apheresis system.
    Tani N
    Artif Organs; 1996 Aug; 20(8):922-9. PubMed ID: 8853808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.